Market Summery
Infertility is a medical condition in which male or female
members are unable to reproduce or have children. Common conditions for the
condition include low sperm motility, genetic deficiencies, and psychological
issues. According to the Centers for Disease Control & Prevention (CDC),
close to 6% unmarried women are unable to attain pregnancy even after
unprotected intercourse. The global infertility market report compiled by
Market Research Future (MRFR) contains pertinent factors and challenges of
customers as well as efforts of industry stalwarts in easing the process of
reproduction.
The Infertility
Market Share is anticipated to grow at CAGR of 12.8 % and will reach a
valuation of USD 4.72 billion during the forecast period 2023-2032.
Major growth drivers of the market include late marriages,
sedentary lifestyles, genetic deficiencies, environmental factors, and health
history.
Market Outlook
Awareness of the condition and preventive measures in terms
of treatment is likely to drive the market growth. Emergence of various clinics
which can conduct tests discreetly can bode well for the market. In addition,
the recognition of infertility as a disease by insurance organizations and
coverage packages being dispensed to patients is a sign of the large potential
of the market. Technological advances in terms of artificial reproduction
technique (ART) and artificial insemination are predicted to bolster the global
infertility market growth. Successful outcomes of such methods as well as
conduction of clinical trials for safe methods of conception among couples are
other major drivers of the market.
High Infertility treatment costs, side effects of infertility
treatment, and societal taboos are factors which can impede market growth.
Competitive Outlook-
·
SCSA Diagnostics, Inc.,
·
Bayer Healthcare,
·
EMD Serono, Inc.,
·
Zydus Cadila Healthcare Ltd,
·
Aetna Inc.,
·
Androvia LifeSciences,
·
Andrology Solutions,
·
Halotech DNA,
and others are prominent names within the global infertility
market players.
Segmentation Analysis
The global infertility
market outlook report is segmented by sex, diagnosis, drugs, and
techniques.
·
By sex, it is segmented into male,
female, and unexplained.
·
By diagnosis, it is segmented infertility
statistics worldwide into men diagnostic tests, female diagnostic tests,
and general diagnostic tests. Testicular biopsy, genetic testing, semen
analysis, and others are major sub-segments within the men diagnostic tests
segment. Female diagnostic tests, on the other hand, is segmented into
hysterosalpingography, hysteroscopy, laparoscopy, ovulation testing, and
others. Microscopic analysis, imaging, hormone testing, genetic testing, and
others are segments within general diagnostic tests.
·
By drugs, it is segmented into seraphine,
clomiphene citrate, letrozole, hormone treatment, and others.
·
By techniques, it is segmented into
assisted reproductive technology (ART), surgery, and intrauterine insemination.
Surgery is further segmented into tubal surgeries, laparoscopic or
hysteroscopic surgery, and others.
Regional Analysis
North America, Asia Pacific, Europe, and the Middle East
& Africa (MEA) are the regions being considered for the basis of the
report.
North America is predicted to dominate the market led by the
U.S. Factors facilitating regional market growth include rise in awareness
levels of patients, high expendable income levels of patients, and
reimbursement schemes.
Europe is expected to be the second largest region led by
France, Germany, and the U.K. Changes in lifestyles of patients and delayed
pregnancies are factors which can drive the need for fertility treatments. In
addition, the successful outcomes of fertility clinics as well as rise in
cryopreservation can contribute to the global infertility treatment in paris.
Industry News
·
Seed funding to accelerate research and
development efforts put into fertility treatments is expected to increase due
to successful outcomes as well as demand for affordable treatment methods.
Recently, Mojo is planning to raise USD 1.8 million in capital with the help of
Nordic firm, Inventure. The firm plans to use robotics and artificial
intelligence to assist in egg and sperm quality analysis as well as develop
methods to lower fertilization costs.
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
